Literature DB >> 15284402

Canine atopic dermatitis: new targets, new therapies.

Douglas J DeBoer1.   

Abstract

Atopic dermatitis is a common allergic skin disease of complex etiopathogenesis in both humans and dogs. Immediate-type hypersensitivity to environmental allergens that arises as a result of environmental and genetic factors is a major part of the pathogenesis in most but not all patients. Alterations in epidermal barrier function, priming of cutaneous antigen-presenting cells with IgE, intrinsic keratinocyte defects, and even development of autoimmunity are also factors that contribute to the primary disease. Secondary factors, especially infections with Staphylococcus and yeast organisms, strongly influence the course of this skin disease. The relatively recent understanding of the complexities of atopic dermatitis has resulted in changes in diagnostic and therapeutic strategies for the disease. We now know that the best therapeutic approach is to use combinations of multiple modalities individualized for each patient over the course of his or her lifetime.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284402     DOI: 10.1093/jn/134.8.2056S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  2 in total

1.  Incubation of canine dermal fibroblasts with serum from dogs with atopic dermatitis activates extracellular matrix signalling and represses oxidative phosphorylation.

Authors:  Monica Colitti; Bruno Stefanon; Misa Sandri; Danilo Licastro
Journal:  Vet Res Commun       Date:  2022-06-04       Impact factor: 2.459

2.  Evaluation of the effect of a 0.0584% hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis.

Authors:  Eui-Hwa Nam; Seol-Hee Park; Ji-Young Jung; Seung-Hee Han; Hwa-Young Youn; Jun-Seok Chae; Cheol-Yong Hwang
Journal:  J Vet Sci       Date:  2012-06       Impact factor: 1.672

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.